Co-Diagnostics Reports Full Year 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- S&P 500, Nasdaq futures tick up as tech steadies, Micron earnings eyed
- Brent extends losses on expectations of smoother crude flows via Hormuz
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Co-Diagnostics (CODX) Reports FY21 $97.9M, EPS of $1.23
March 24, 2022 4:02 PM EDTCo-Diagnostics (NASDAQ: CODX) reported Q4 EPS of $, $0.12 worse than the analyst estimate of $0.12. Revenue for the quarter came in at $0 versus the consensus estimate of $20.93 million.
GUIDANCE:
Co-Diagnostics sees Q1 2022 EPS of $0.17-$0.20. Co-Diagnostics sees Q1 2022 revenue of $21-22... More
